Cancers | Free Full-Text | Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review - ScienceDirect
HER2 in colorectal cancer: guidance for pathologists receiving requests for testing
The HER family as therapeutic targets in colorectal cancer - ScienceDirect
HER2 expression and copy number alterations in colorectal cancer (CRC).... | Download Scientific Diagram
EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer | Scientific Reports
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models | Journal of Experimental & Clinical Cancer Research | Full Text
![en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada](https://www.colorectalcancercanada.com/wp-content/uploads/2023/08/her2receptor.png "en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada")
en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
Hitting the Target in HER2-Positive Metastatic Colorectal Cancer | PPT
Detecting HER2 Amplification in Colorectal Cancer
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti‐Epidermal Growth Factor Receptor Therapy | Semantic Scholar
HER2/neu testing in primary colorectal carcinoma | British Journal of Cancer
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
HER2 evaluation by immunohistochemistry and fluorescence in situ... | Download Scientific Diagram
Life | Free Full-Text | HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - ScienceDirect
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression | PLOS ONE
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
